Nutranomics, Inc. (NNRX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nutranomics, Inc. (NNRX). Nutranomics, Inc. focuses on researching, developing, and selling nutritional food products and supplements. The company distributes its products through sales representatives and retail stores across North America and Asia. Sector: Healthcare.
Last analyzed: Mar 16, 2026NNRX: 1/1 perspectives are bearish.
Nutranomics, Inc. (NNRX) Healthcare & Pipeline Overview
Nutranomics, Inc., founded in 1995, operates in the nutritional supplement market, offering a range of products including vitamin, mineral, and herbal supplements. The company distinguishes itself through its Nutritional Blood Analysis tool and patented Assimilation Enhancing System, distributing products via sales representatives and retail channels in North America and Asia.
What Is the Investment Thesis for NNRX?
Nutranomics, Inc. presents a challenging investment case given its negative profit and gross margins of -232.9% and -108.0%, respectively. The company's small market capitalization and OTC listing introduce liquidity and regulatory risks. A potential growth catalyst lies in expanding its distribution network in Asia and North America. The company's proprietary Nutritional Blood Analysis tool and Assimilation Enhancing System could offer a competitive edge if effectively marketed. However, the company's financial performance and OTC status require careful consideration.
Based on FMP financials and quantitative analysis
NNRX Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.07 suggests the company is not currently profitable.
- Profit margin of -232.9% reflects significant losses relative to revenue.
- Gross margin of -108.0% indicates that the cost of goods sold exceeds revenue.
- Beta of -0.06 suggests the stock price is less volatile than the overall market.
Who Are NNRX's Competitors?
Who Are NNRX's Competitors?
NNRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AXRX Amexdrug Corporation | $0.00 | +0.00% | 34K | — |
| ALVO Alvotech | $3.36 | +3.59% | $1.05B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| MPXOF MPX International Corporation | $0.00 | +0.00% | 2K | 68 |
| AGRX Agile Therapeutics, Inc. | $1.51 | +3.42% | 11M | 59 |
| KHRNF Khiron Life Sciences Corp. | $0.00 | +0.00% | 2K | 59 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.36 | -82.11% | $4.80M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NNRX's Key Strengths?
- Proprietary Nutritional Blood Analysis tool.
- Patented Assimilation Enhancing System.
- Established distribution network in North America and Asia.
- Wide range of nutritional supplements (approximately 480 products).
What Are NNRX's Weaknesses?
- Negative profit and gross margins.
- Small market capitalization.
- Limited financial resources.
- OTC listing introduces liquidity and regulatory risks.
What Could Drive NNRX Stock Higher?
- Expansion of distribution network in Asian markets.
- Development of enhanced online presence and e-commerce platform.
- Formation of strategic partnerships with healthcare providers and wellness centers.
- Product innovation and development of differentiated supplements.
What Are the Key Risks for NNRX?
- Intense competition in the dietary supplements industry.
- Evolving regulatory landscape and compliance requirements.
- Changing consumer preferences and trends.
- Product liability claims.
- Negative profit and gross margins.
What Are the Growth Opportunities for NNRX?
- Expansion in Asian Markets: Nutranomics can leverage the growing demand for nutritional supplements in Asia, particularly in countries with aging populations and increasing health awareness. The Asian dietary supplements market is projected to reach $XX billion by 2028. Establishing strategic partnerships with local distributors and tailoring products to meet specific regional needs could drive significant revenue growth. Timeline: Ongoing.
- Enhanced Online Presence: Developing a robust e-commerce platform and strengthening its online marketing efforts can broaden Nutranomics' reach and cater to the increasing number of consumers who prefer online shopping. The global e-commerce market for health and wellness products is expected to reach $YY billion by 2027. Investing in SEO, social media marketing, and targeted advertising can drive online sales. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic alliances with healthcare providers, wellness centers, and fitness studios can provide Nutranomics with access to new customer segments and enhance its brand credibility. Collaborating with these partners to offer bundled products and services can create synergistic value and drive sales. Timeline: Ongoing.
- Product Innovation: Investing in research and development to create innovative and differentiated nutritional supplements can provide Nutranomics with a competitive edge. Focusing on emerging trends such as personalized nutrition and plant-based supplements can attract health-conscious consumers. Timeline: Ongoing.
- Educational Initiatives: Expanding its educational services, including analyses, training programs, and certifications, can establish Nutranomics as a trusted source of information and drive demand for its products. Offering online courses and webinars can reach a wider audience and generate leads. Timeline: Ongoing.
What Opportunities Does NNRX Have?
- Expansion in Asian markets.
- Enhanced online presence and e-commerce platform.
- Strategic partnerships with healthcare providers and wellness centers.
- Product innovation and development of differentiated supplements.
What Threats Does NNRX Face?
- Intense competition in the dietary supplements industry.
- Evolving regulatory landscape and compliance requirements.
- Changing consumer preferences and trends.
- Potential for product liability claims.
What Are NNRX's Competitive Advantages?
- Patented Assimilation Enhancing System provides a unique selling proposition.
- Nutritional Blood Analysis tool offers a differentiated customer experience.
- Established distribution network in North America and Asia.
- Long-standing presence in the nutritional supplement market (founded in 1995).
What Does NNRX Do?
Nutranomics, Inc., established in 1995, is a healthcare company focused on the research, development, and sale of nutritional food products. The company offers a diverse portfolio of approximately 480 nutritional supplements, encompassing vitamin, mineral, herbal, and probiotic formulations. A key differentiator for Nutranomics is its proprietary Nutritional Blood Analysis, a real-time video monitoring tool used to examine a customer's blood cells. Complementing this is the patented Assimilation Enhancing System, designed to improve nutrient absorption. Beyond product offerings, Nutranomics provides educational services, including various analyses, training programs, certifications, and group presentations catering to both individuals and industry professionals. The company utilizes a distribution network comprising sales representatives throughout North America and Asia, alongside retail store partnerships. Nutranomics also maintains a strategic partnership with Terra-Formance, LLC. Headquartered in Salt Lake City, Utah, Nutranomics continues to operate in the competitive nutritional supplement market.
What Products and Services Does NNRX Offer?
- Researches and develops nutritional food products.
- Formulates and sells approximately 480 nutritional supplements.
- Offers vitamin, mineral, herbal, and probiotic supplements.
- Provides Nutritional Blood Analysis using real-time video monitoring.
- Offers the patented Assimilation Enhancing System to improve nutrient absorption.
- Provides educational services, including analyses, trainings, and certifications.
- Distributes products through sales representatives in North America and Asia.
- Sells products through retail stores.
How Does NNRX Make Money?
- Sells nutritional supplements directly to consumers through sales representatives.
- Generates revenue through retail partnerships and distribution agreements.
- Offers educational services and training programs for additional income.
- Licenses its patented Assimilation Enhancing System.
What Industry Does NNRX Operate In?
Nutranomics, Inc. operates within the competitive dietary supplements industry. This industry is characterized by increasing consumer interest in health and wellness, driving demand for vitamins, minerals, and herbal supplements. However, the market is also highly fragmented, with numerous players ranging from large multinational corporations to smaller, niche-focused companies. Regulatory scrutiny and evolving consumer preferences pose ongoing challenges. Competitors like ACUR, AXRX, ENDV, FLHLF, and MEDD also operate in this space, creating a crowded market.
Who Are NNRX's Key Customers?
- Health-conscious individuals seeking nutritional supplements.
- Retail stores and distributors in North America and Asia.
- Healthcare professionals and wellness centers.
- Individuals seeking educational services related to nutrition.
NNRX Financials
NNRX Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Friday
· Oct 25, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 1, 2019
NNRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NNRX.
Price Targets
Wall Street price target analysis for NNRX.
NNRX MoonshotScore
What does this score mean?
The MoonshotScore rates NNRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Who Are NNRX's Competitors?
Leadership: Jonathan Bishop
CEO
Jonathan Bishop is the CEO of Nutranomics, Inc. His background includes experience in managing small teams and overseeing the operations of the company. Information regarding his specific educational background and previous roles is not available. He is responsible for the strategic direction and overall performance of Nutranomics, Inc., which currently employs one individual.
Track Record: Under Jonathan Bishop's leadership, Nutranomics, Inc. has continued to offer a range of nutritional supplements and related services. Specific milestones and achievements during his tenure are not detailed in the provided information. His focus remains on maintaining the company's existing product lines and distribution channels.
NNRX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nutranomics, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, minimal assets, and may be subject to greater regulatory scrutiny. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer listing requirements, resulting in increased risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume on the OTC Other market.
- Lack of transparency regarding financial reporting and disclosure.
- Potential for price manipulation and fraud.
- Higher risk of delisting or trading suspension.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and potential conflicts of interest.
- Check for any history of fraud or regulatory violations.
- Consult with a qualified financial advisor before investing.
- Long-standing presence in the nutritional supplement market (founded in 1995).
- Proprietary Nutritional Blood Analysis tool.
- Patented Assimilation Enhancing System.
- Distribution network in North America and Asia.
NNRX Healthcare Stock FAQ
What does Nutranomics, Inc. do?
Nutranomics, Inc. is involved in the research, development, and sale of nutritional food products and supplements. The company offers a range of approximately 480 nutritional supplements, including vitamins, minerals, herbal remedies, and probiotics. It also provides the Nutritional Blood Analysis tool and the patented Assimilation Enhancing System. Nutranomics distributes its products through sales representatives and retail stores across North America and Asia.
What do analysts say about NNRX stock?
AI analysis is currently pending for NNRX. Given the company's OTC listing and limited financial information, analyst coverage is likely to be minimal. Investors should conduct their own thorough due diligence and consult with a qualified financial advisor before making any investment decisions. Key valuation metrics to consider include market capitalization, revenue growth, and profitability.
What are the main risks for NNRX?
The main risks for Nutranomics, Inc. include its negative profit and gross margins, small market capitalization, and OTC listing. The company faces intense competition in the dietary supplements industry and must navigate an evolving regulatory landscape. Product liability claims and changing consumer preferences also pose potential threats. Limited liquidity and transparency associated with the OTC market further increase the risk for investors.
What are the key factors to evaluate for NNRX?
Evaluating NNRX involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Proprietary Nutritional Blood Analysis tool. Primary risk to monitor: Intense competition in the dietary supplements industry. This is not financial advice.
How frequently does NNRX data refresh on this page?
NNRX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NNRX's recent stock price performance?
Recent price movement in Nutranomics, Inc. (NNRX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary Nutritional Blood Analysis tool. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NNRX overvalued or undervalued right now?
Determining whether Nutranomics, Inc. (NNRX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NNRX?
Before investing in Nutranomics, Inc. (NNRX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market investments carry significant risks.
- AI analysis is pending and may provide further insights.